Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.

Authors

A Berruti¹, E Baudin, H Gelderblom, H R Haak, F Porpiglia, M Fassnacht, G Pentheroudakis, ESMO Guidelines Working Group

Affiliation

¹ Department of Clinical and Biological Sciences, University of Torino, Azienda Ospedaliero, Universitaria San Luigi, Orbassano, Italy.

PMID: 22997446
DOI: 10.1093/annonc/mds231

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Adrenal Gland Neoplasms / diagnosis*
Adrenal Gland Neoplasms / pathology
Adrenal Gland Neoplasms / therapy
Adrenalectomy
Adrenocortical Carcinoma / diagnosis*
Adrenocortical Carcinoma / secondary
Adrenocortical Carcinoma / therapy
Antineoplastic Agents, Hormonal / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chemoradiotherapy, Adjuvant
Humans
Mitotane / therapeutic use
Neoplasm Staging
Neoplasms, Hormone-Dependent / diagnosis*
Neoplasms, Hormone-Dependent / pathology
Neoplasms, Hormone-Dependent / therapy
Pheochromocytoma / diagnosis*
Pheochromocytoma / secondary
Pheochromocytoma / therapy
Risk Assessment

Substances

Antineoplastic Agents, Hormonal
Mitotane